Clinical Trial Update: Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing candesartan versus lercanidipine for hypertension in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hypertension

Drugs mentioned

• Candesartan (candesartan)
• Lercanidipine (lercanidipine)

Snippet

Sponsor: Università degli Studi dell'Insubria | Conditions: HIV Infections, Hypertension | Phase 4 | Status: UNKNOWN